Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bvf Inc/il
Relationship:   Indirect Beneficial Ow...
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   12    
Direct Shares   49,829,941    

Indirect Shares

   136,880,248      
Direct Value   $2,543,314,200    

Indirect Value

   $7,622,100,274      
Total Shares   186,710,189      
Total Value   $10,165,414,474      


Neurocrine Biosciences Inc $708,575,376 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $49,035,632 Ligand Pharmaceuticals Inc $1,319,785,650 Curis Inc $3,390,252 Repligen Corp $461,473,020 Gyre Therapeutics $1,054,262 Neurocrine Biosciences Inc $708,575,376 Neurobiological Technologies Inc $0 Epirus Biopharmaceuticals Inc $7 Adolor Corp $0 Dynavax Technologies Corp $49,035,632 Ligand Pharmaceuticals Inc $1,319,785,650 Curis Inc $3,390,252 Repligen Corp $461,473,020 Gyre Therapeutics $1,054,262
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    19   
    2    

     Stock price went up :
    18   
    0    
     Stock price went down :
    1   
    2    
   
     Gain/Loss Ratio :
   18.0   
   -2.0   
     Percentage Gain/Loss :
   64.8%
 -200.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Neurocrine Biosciences Inc NBIX 10% Owner 2010-04-12 5,041,447 2010-04-12 15,124,341    Premium*  
            NPS Pharmaceuticals Inc NPSP Indirect Beneficial Ow... 2008-03-11 0 2008-09-22 4,383,115    Premium*  
            Astex Pharmaceuticals Inc ASTX Indirect Beneficial Ow... 2008-05-01 0 2008-05-09 5,753,399    Premium*  
            Neurobiological Technologies Inc NTII 10% Owner 2009-10-21 331,998 2009-10-21 995,994    Premium*  
            Epirus Biopharmaceuticals Inc EPRS 10% Owner 2009-12-22 6,830,972 2009-12-22 20,492,916    Premium*  
            Capstone Therapeutics Corp CAPS Indirect Beneficial Ow... 2008-10-10 0 2008-10-14 5,136,888    Premium*  
            Adolor Corp ADLR Indirect Beneficial Ow... 2008-10-10 4,428,032 2008-10-31 6,214,551    Premium*  
            Dynavax Technologies Corp DVAX 10% Owner 2009-09-10 4,278,851 2009-09-10 12,836,553    Premium*  
            Ligand Pharmaceuticals Inc LGND Indirect Beneficial Ow... 2009-07-01 15,169,950 2009-07-01 45,509,850    Premium*  
            Curis Inc CRIS Indirect Beneficial Ow... 2009-02-03 8,921,716 2009-04-27 5,951,716    Premium*  
            Repligen Corp RGEN Indirect Beneficial Ow... 2009-07-07 2,765,050 2009-07-07 8,295,150    Premium*  
            Gyre Therapeutics GYRE Indirect Beneficial Ow... 2009-10-16 2,061,925 2009-10-16 6,185,775    Premium*  
* Premium Members only  

Records found :    195         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-28 4 B $2.75 $3,738,985 I/I 1,351,119 6,125,651 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-29 4 B $2.79 $157,632 I/I 56,400 6,182,051 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-30 4 B $2.94 $92,667 I/I 31,500 6,213,551 1.5 -
ADLR Adolor Corp Indirect Beneficial Owner   –       –       •   2008-10-31 4 B $2.95 $2,950 I/I 1,000 6,214,551 1.42 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-05 4 B $0.60 $108,186 I/I 180,400 8,008,199 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-06 4 B $0.59 $6,584 I/I 11,200 8,019,399 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-07 4 B $1.41 $159,319 I/I 113,000 9,886,948 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-07 4 B $0.58 $63,264 I/I 109,700 8,129,099 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-10 4 B $1.36 $270,072 I/I 198,000 10,084,948 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-10 4 B $0.58 $8,120 I/I 14,000 8,143,099 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-11-10 4 B $2.35 $3,145,475 I/I 1,338,500 10,819,560 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-11 4 B $1.39 $233,429 I/I 167,850 10,252,798 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-11 4 B $0.60 $83,224 I/I 139,100 8,282,199 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-11-11 4 B $2.25 $927,450 I/I 412,200 11,231,760 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-12 4 B $0.60 $2,159 I/I 3,600 8,285,799 1.42 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-12 4 B $1.35 $19,571 I/I 14,511 10,267,309 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-11-12 4 B $2.45 $923,650 I/I 377,000 11,608,760 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-13 4 B $0.60 $5,400 I/I 9,000 8,294,799 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-13 4 B $1.34 $126,233 I/I 94,000 10,361,309 1.5 -
EPRS Epirus Biopharmaceuticals... Indirect Beneficial Owner   –       –       •   2008-11-14 4 B $0.60 $5,486 I/I 9,200 8,303,999 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-14 4 B $1.30 $273,050 I/I 210,000 10,571,309 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-17 4 B $1.33 $122,323 I/I 92,000 10,663,309 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-18 4 B $1.38 $112,536 I/I 81,400 10,744,709 1.5 -
ARQL Arqule Inc Indirect Beneficial Owner   –       –       •   2008-11-19 4 B $2.65 $780,194 I/I 294,413 11,903,173 1.5 -
LGND Ligand Pharmaceuticals In... Indirect Beneficial Owner   –       –       •   2008-11-19 4 B $1.39 $45,906 I/I 33,000 10,777,709 1.5 -
  195  Records found
  1   2   3   4   5   6  7   8      
  Page 6 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us